On May 21, 2024, Quest Diagnostics Incorporated announced that it held its annual general meeting of shareholders on May 16, 2024, and declared voting results. Accordingly, a shareholder proposal regarding managing climate risk through science-based targets and transition planning, submitted by John Chevedden, was not approved by the Company shareholders.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
137.8 USD | -0.49% | -3.15% | -0.02% |
06-11 | Quest Diagnostics Completes Acquisition of PathAI Diagnostics From PathAI | MT |
06-11 | Quest Diagnostics Completes Acquisition of PathAI Diagnostics From PathAI | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.02% | 15.31B | |
+24.67% | 88.39B | |
-23.73% | 75.6B | |
+3.24% | 26.87B | |
+5.31% | 17.81B | |
-12.06% | 16.85B | |
+75.93% | 13.53B | |
+82.63% | 13.48B | |
-24.56% | 13.01B | |
+23.23% | 12.57B |
- Stock Market
- Equities
- DGX Stock
- News Quest Diagnostics Incorporated
- Declaration of Voting Results by Quest Diagnostics Incorporated